HomeCSMYF • OTCMKTS
add
Cosmos Pharmaceutical Corp
Previous close
$46.06
Year range
$39.22 - $51.06
Market cap
607.08B JPY
Avg Volume
20.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
In the news
Financials
Income Statement
Revenue
Net income
| (JPY) | Nov 2024info | Y/Y change |
|---|---|---|
Revenue | 244.10B | 3.97% |
Operating expense | 42.64B | 9.12% |
Net income | 6.28B | 23.74% |
Net profit margin | 2.57 | 18.98% |
Earnings per share | — | — |
EBITDA | 14.17B | 22.66% |
Effective tax rate | 32.97% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Nov 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 39.13B | 31.77% |
Total assets | 486.57B | 11.56% |
Total liabilities | 243.09B | 12.92% |
Total equity | 243.48B | — |
Shares outstanding | 79.26M | — |
Price to book | 0.01 | — |
Return on assets | 4.57% | — |
Return on capital | 8.32% | — |
Cash Flow
Net change in cash
| (JPY) | Nov 2024info | Y/Y change |
|---|---|---|
Net income | 6.28B | 23.74% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Dec 1983
Website
Employees
5,512
